LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the immediate availability in the United States of Arsenic Trioxide Injection in a 10 mg per 10 mL vial presentation. The product is ...

MDS patients diagnosed according to standard French-American-British criteria received a loading dose of 0.3 mg/kg per day of arsenic trioxide for 5 days followed by a maintenance dose of 0.25 mg/kg ...

Researchers at the LKS Faculty of Medicine of the University of Hong Kong (HKUMed) have invented an oral formulation of arsenic trioxide (Oral-ATO; ARSENOL) for the treatment of acute promyelocytic ...

CD26 expression in donor stem cell harvest and its correlation with engraftment in human haematopoietic stem cell transplantation: Potential predictor of early engraftment. Use of deep whole ...

Researchers at Zhejiang University School of Medicine have identified a single point mutation in the normal PML gene that can block the effect of arsenic trioxide, a frontline drug for acute ...

The use of arsenic trioxide instead of idarubicin in combination with all-trans retinoic acid (ATRA) is a feasible option in patients with acute promyelocytic leukaemia, regardless of risk level, ...

Early studies indicate oral arsenic trioxide provides similar systemic exposure to IV dosing. The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation ...

CHICAGO (Reuters Health) - In adults with newly diagnosed acute promyelocytic leukemia (APL), the addition of arsenic trioxide to standard therapy significantly improves survival, according to a phase ...

Newly published data from a phase IIa drug trial shows the treatment arsenic trioxide (ATO) showed positive results for people with lupus. Initial findings also show encouraging efficacy results for ...

STRASBOURG, France--(BUSINESS WIRE)--Medsenic, a clinical-stage biopharmaceutical company specializing in the discovery and development of new indications and formulations of arsenic salts for the ...